PenMetabolic · NNMT inhibitor
5-Amino-1MQ 25 mg
A selective NNMT inhibitor studied for fat-mass reduction and NAD⁺ research.
View 25 mg
QUADRA-G PENMetabolic · Multi-agonist
Quadra-G 10 mg
Strength 10 mg / 3 mLPurity HPLCForm Pre-filled penCOA Per batch
A multi-target research peptide combining GLP-1, GIP, glucagon and amylin agonism with chemokine-receptor antagonism, studied for metabolic and body-composition endpoints, here as a ready-to-use pen.
Researched directions
- GLP-1 / GIP incretin-pathway research
- Glucagon & amylin metabolic endpoints
- Body-composition and energy-balance models
- Chemokine-receptor antagonism studies
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
About Quadra-G
Quadra-G is a quintuple-agonist research peptide — GLP-1, GIP, glucagon, amylin, and chemokine-receptor antagonism — studied across metabolic and body-composition research models. This 10 mg pen supports repeat-dose study designs.
Features
Quadra-G is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
Related compounds
Back to catalogue Pen
PenLongevity · NAD⁺
NAD+ 1000 mg
The NAD⁺ coenzyme studied for cellular energy, DNA repair and longevity research.
View 1000 mg
Every batch, documented.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.